Cannabics Pharmaceuticals Inc. Stock Other OTC
Equities
CNBX
US13764M1009
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | 410K | Capitalization | 353K |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | - |
Net Debt 2022 | 1.64M | Net Debt 2023 | 1.21M | EV / Sales 2023 | 3.82 x |
P/E ratio 2022 |
-1.12
x | P/E ratio 2023 |
-0.04
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 04-09-14 |
Gabriel Yariv
CHM | Chairman | 47 | 19-10-06 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 16-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 04-09-14 |
Gabriel Yariv
CHM | Chairman | 47 | 19-10-06 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+0.76% | 22.2B | |
-16.53% | 21.23B | |
-8.28% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |